From: Telomere shortening in leukocyte subpopulations in depression
Group | N | Mean | SD | Overall test | CG vs. IS | IS vs. RS | |
---|---|---|---|---|---|---|---|
Age (years) | CG | 50 | 51.1 | 8 | χ2 2 = 2.10, | ||
IS | 24 | 53.1 | 7.2 | p = .35 | |||
RS | 20 | 53.8 | 7.6 | ||||
Education (years) | CG | 50 | 15.1 | 2.4 | χ2 2 = 3.05, | ||
IS | 24 | 14.1 | 2.1 | p = .22 | |||
RS | 20 | 14.2 | 2.9 | ||||
Age at first depressive episode (years) | CG | 50 | - | ||||
IS | 24 | 37.2 | 12.6 | t 36.8 = 1.33, | |||
RS | 20 | 31.5 | 15.4 | p = .19 | |||
Total depressive episodes | CG | 50 | - | - | |||
IS | 24 | 2.4 | 1.0 | W = 176.5, | |||
RS | 20 | 3.2 | 2.1 | p = .27 | |||
BDI | CG | 50 | 3.2 | 2.8 | χ2 2 = 53.7, | W = 253, | W = 5.5, |
IS | 24 | 7.5 | 4.8 | p < .0001 | p = .0003 | p < .0001 | |
RS | 20 | 21.7 | 7.4 | ||||
SSRI/ SNRI intake | CG | 0 of 50 | |||||
IS | 10 of 24 | χ 2 2 = .33, | |||||
RS | 9 of 20 | p = .56 | |||||
L-Thyroxine intake | CG | 3 of 50 | χ2 2 = 1.26, | ||||
IS | 1 of 24 | p = .53 | |||||
RS | 0 of 20 | ||||||
CD4+ TL (%) | CG | 48 | 67.77 | 16.05 | See text for detailed models and results | ||
IS | 24 | 55.06 | 15.73 | ||||
RS | 20 | 53.09 | 17.88 | ||||
CD8+ TL (%) | CG | 45 | 68.7 | 13.69 | See text for detailed models and results | ||
IS | 24 | 51.1 | 11.98 | ||||
RS | 17 | 48.76 | 13.07 | ||||
CD20+ TL (%) | CG | 44 | 68.83 | 16.83 | See text for detailed models and results | ||
IS | 23 | 47.44 | 9.44 | ||||
RS | 16 | 50 | 13.69 | ||||
Hypertension | CG | 1 of 50 | |||||
IS | 1 of 24 | ||||||
RS | 2 of 20 |